Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUNLUN ENERGY
00135
5
CHINA OILFIELD
02883
HK Stock MarketDetailed Quotes
CSPC PHARMA (01093)
- 7.340
- -0.050-0.68%
Not Open May 21 16:07 CST
84.57BMarket Cap19.68P/E (TTM)
7.510High7.280Low58.07MVolume7.430Open7.390Prev Close428.11MTurnover0.50%Turnover Ratio19.68P/E (Static)11.52BShares11.49052wk High2.30P/B84.57BFloat Cap6.21052wk Low0.24Dividend TTM11.52BShs Float12.459Historical High0.262Dividend LFY3.11%Range %-2.039Historical Low7.372Avg Price2000Lot Size3.27%Div Yield TTM3.57%Div Yield LFY
CSPC PHARMA (01093) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -13.81%4.81B | ---- | -24.50%5.58B | ---- | -2.54%7.39B | ---- | 10.74%7.58B | ---- | 7.14%6.85B | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 15.75%-195.87M | ---- | 10.54%-232.5M | ---- | -0.40%-259.88M | ---- | -34.65%-258.84M | ---- | -67.54%-192.22M | ---- |
| Attributable subsidiary (profit) loss | -41.39%52.45M | ---- | 65.09%89.47M | ---- | 252.04%54.2M | ---- | 168.60%15.4M | ---- | -65.85%-22.44M | ---- |
| Impairment and provisions: | -116.87%-2.75M | ---- | -73.13%16.3M | ---- | 34.22%60.67M | ---- | -12.80%45.2M | ---- | 71.15%51.83M | ---- |
| -Impairmen of inventory (reversal) | ---2.76M | ---- | ---- | ---- | 95.13%-57K | ---- | 47.67%-1.17M | ---- | -220.34%-2.24M | ---- |
| -Other impairments and provisions | -99.97%5K | ---- | -73.15%16.3M | ---- | 30.96%60.73M | ---- | -14.24%46.37M | ---- | 90.21%54.07M | ---- |
| Revaluation surplus: | -421.16%-335.5M | ---- | -15.40%104.47M | ---- | 156.56%123.48M | ---- | 23.81%-218.34M | ---- | 50.45%-286.57M | ---- |
| -Other fair value changes | -421.16%-335.5M | ---- | -15.40%104.47M | ---- | 156.56%123.48M | ---- | 23.81%-218.34M | ---- | 50.45%-286.57M | ---- |
| Asset sale loss (gain): | -29.60%16.47M | ---- | 320.01%23.4M | ---- | 73.87%-10.64M | ---- | -53.14%-40.7M | ---- | 91.71%-26.58M | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | 31.63%-32.86M | ---- | -267.13%-48.07M | ---- | 96.07%-13.09M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -29.60%16.47M | ---- | 5.27%23.4M | ---- | 201.94%22.23M | ---- | -31.75%7.36M | ---- | -12.92%10.79M | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---24.27M | ---- |
| Depreciation and amortization: | 5.47%1.41B | ---- | 19.86%1.34B | ---- | 6.64%1.12B | ---- | 21.08%1.05B | ---- | 7.01%865.47M | ---- |
| -Amortization of intangible assets | 3.81%154.75M | ---- | 79.92%149.07M | ---- | -8.30%82.86M | ---- | 256.26%90.35M | ---- | 67.72%25.36M | ---- |
| Financial expense | -11.63%38.6M | ---- | 68.65%43.67M | ---- | 4.04%25.9M | ---- | 224.78%24.89M | ---- | -37.34%7.66M | ---- |
| Special items | -437.46%-276.25M | ---- | 326.31%81.86M | ---- | 156.02%19.2M | ---- | 56.34%-34.28M | ---- | 16.98%-78.52M | ---- |
| Operating profit before the change of operating capital | -21.67%5.52B | ---- | -17.31%7.04B | ---- | 4.36%8.52B | ---- | 13.92%8.16B | ---- | 17.08%7.17B | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 385.94%42.03M | ---- | 101.48%8.65M | ---- | -1,265.49%-583.75M | ---- | 93.07%-42.75M | ---- | -202.60%-617.07M | ---- |
| Accounts receivable (increase)decrease | 147.39%211.57M | ---- | 86.44%-446.43M | ---- | -628.86%-3.29B | ---- | 77.52%-451.72M | ---- | -4,314.57%-2.01B | ---- |
| Accounts payable increase (decrease) | 146.19%138.65M | ---- | -127.32%-300.2M | ---- | 23.93%1.1B | ---- | -41.06%886.61M | ---- | 97.72%1.5B | ---- |
| prepayments (increase)decrease | -189.33%-620.34M | ---- | -1,142.36%-214.4M | ---- | 132.83%20.57M | ---- | 71.70%-62.65M | ---- | -407.78%-221.36M | ---- |
| Special items for working capital changes | 911.05%1.37B | ---- | 149.12%135.12M | ---- | -158.70%-275.07M | ---- | 1,159.77%468.63M | ---- | -115.17%-44.22M | ---- |
| Cash from business operations | 6.88%6.66B | ---- | 13.48%6.23B | ---- | -38.76%5.49B | ---- | 55.10%8.96B | ---- | -25.93%5.78B | ---- |
| Other taxs | 51.30%-824.44M | ---- | -29.32%-1.69B | ---- | 1.91%-1.31B | ---- | -16.95%-1.33B | ---- | -7.56%-1.14B | ---- |
| Special items of business | ---- | 123.61%3.19B | ---- | 7.95%1.43B | ---- | -68.98%1.32B | ---- | 55.22%4.26B | ---- | 12.91%2.74B |
| Net cash from operations | 28.60%5.83B | 123.61%3.19B | 8.52%4.53B | 7.95%1.43B | -45.21%4.18B | -68.98%1.32B | 64.50%7.63B | 55.22%4.26B | -31.20%4.64B | 12.91%2.74B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -15.75%195.87M | -19.67%100.24M | -10.54%232.5M | -0.02%124.78M | 7.16%259.88M | 26.74%124.81M | 32.36%242.53M | 31.29%98.48M | 99.32%183.24M | 183.59%75.01M |
| Dividend received - investment | 11.24%27.89M | -20.22%20M | 25.35%25.07M | --25.07M | -72.05%20M | ---- | 59.03%71.56M | 188.44%129.8M | --45M | --45M |
| Restricted cash (increase) decrease | 224.20%31.6M | ---- | -148.21%-25.45M | ---- | --52.78M | ---- | ---- | ---5.27M | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 456.98%611.54M | 14.65%609.34M |
| Decrease in deposits (increase) | -0.87%-988.54M | -106.53%-258M | -644.44%-980M | -129.62%-124.92M | 109.61%180M | 112.83%421.71M | -1,090.39%-1.87B | -94.74%-3.29B | 35.22%-157.36M | -2,948.13%-1.69B |
| Sale of fixed assets | -99.84%156K | -89.37%5.3M | -28.62%99.92M | 231.69%49.9M | 731.65%139.99M | -48.74%15.04M | -80.36%16.83M | 671.07%29.35M | 197.21%85.69M | 295.22%3.81M |
| Purchase of fixed assets | 2.78%-1.96B | -85.34%-1.2B | -24.11%-2.02B | 17.30%-649.2M | 26.87%-1.62B | 3.54%-785.01M | -57.45%-2.22B | -40.27%-813.86M | -3.97%-1.41B | 30.93%-580.19M |
| Purchase of intangible assets | 51.60%-321.23M | -129.98%-223.81M | -146.37%-663.66M | 59.30%-97.32M | 46.39%-269.38M | -67.21%-239.11M | -44.26%-502.47M | -74.73%-143M | -58.06%-348.3M | 60.33%-81.84M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 161.97%185.56M | 130.86%185.56M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---341.91M | ---301.72M | ---- | ---- |
| Recovery of cash from investments | 49.23%1.98B | -55.70%157.04M | -70.38%1.33B | -87.45%354.51M | 36.89%4.48B | 347.30%2.82B | -30.42%3.27B | -51.57%631.44M | 15.92%4.7B | 242.18%1.3B |
| Cash on investment | -66.65%-3.34B | 52.29%-886.34M | 21.08%-2B | -41.65%-1.86B | 54.06%-2.54B | 35.86%-1.31B | -21.57%-5.52B | 2.17%-2.05B | -13.69%-4.54B | -74.43%-2.09B |
| Other items in the investment business | 238.91%495.38M | 313.39%172.34M | -13.54%146.17M | -24.06%41.69M | 156.93%169.07M | 1,076.51%54.9M | 408.80%65.8M | -99.10%4.67M | 178.91%12.93M | -53.42%519.12M |
| Net cash from investment operations | -0.51%-3.88B | 0.80%-2.12B | -545.59%-3.86B | -293.05%-2.13B | 112.74%865.86M | 119.38%1.11B | -966.33%-6.8B | -235.61%-5.7B | 70.07%-637.33M | -132.09%-1.7B |
| Net cash before financing | 188.80%1.95B | 251.27%1.07B | -86.59%676.46M | -129.19%-707.98M | 507.00%5.04B | 267.73%2.43B | -79.22%831.08M | -238.60%-1.45B | -13.25%4B | -38.51%1.04B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -25.00%21M | --21M | --28M | ---- | ---- | ---- | --485.71M | --333.58M | ---- | ---- |
| Refund | -212.85%-28M | ---- | 67.85%-8.95M | -71.88%-8.77M | 94.38%-27.84M | ---5.1M | -400.72%-495.71M | ---- | ---99M | ---99M |
| Issuing shares | -78.50%22.88M | -97.44%2.73M | --106.43M | 79.82%106.43M | ---- | --59.19M | ---- | ---- | ---- | ---- |
| Interest paid - financing | -43.44%-10.97M | -6.50%-4.85M | 52.19%-7.65M | 53.85%-4.55M | 25.75%-15.99M | -1.44%-9.86M | -181.03%-21.54M | -103.22%-9.72M | 37.34%-7.66M | -3.37%-4.78M |
| Dividends paid - financing | 24.85%-2.5B | 99.56%-7.17M | -21.08%-3.33B | -32.58%-1.63B | -29.98%-2.75B | -18.28%-1.23B | -24.32%-2.12B | -14.32%-1.04B | -10.93%-1.7B | -12,891.14%-909.38M |
| Absorb investment income | ---- | ---- | -99.60%2.12M | -99.60%1.96M | 910.24%523.99M | 841.09%488.13M | --51.87M | --51.87M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | 82.42%-277.63M | 21.39%-277.63M | -688.14%-1.58B | -76.27%-353.17M | -1,309.88%-200.36M | -1,309.88%-200.36M | 94.61%-14.21M | ---14.21M | ---263.51M | ---- |
| Other items of the financing business | 195.52%304.21M | 134.94%114.98M | -718.78%-318.46M | 1.46%-329.05M | -84.52%51.47M | -1,549.49%-333.94M | --332.48M | ---20.25M | ---- | ---- |
| Net cash from financing operations | 50.29%-2.61B | 90.20%-224.23M | -105.24%-5.25B | -75.72%-2.29B | -34.43%-2.56B | -71.78%-1.3B | 13.32%-1.9B | 29.52%-758.22M | -49.33%-2.2B | -912.28%-1.08B |
| Effect of rate | -241.63%-4.81M | -180.54%-985K | -30.52%3.4M | -79.40%1.22M | -65.39%4.89M | -38.10%5.94M | 678.40%14.14M | 458.18%9.59M | -216.33%-2.44M | -402.60%-2.68M |
| Net Cash | 85.62%-658.06M | 128.26%846.72M | -284.17%-4.58B | -366.84%-3B | 331.60%2.49B | 150.95%1.12B | -159.52%-1.07B | -6,674.28%-2.2B | -42.57%1.8B | -101.78%-32.54M |
| Begining period cash | -43.59%5.92B | -43.59%5.92B | 31.12%10.49B | 31.12%10.49B | -11.69%8B | -11.69%8B | 24.80%9.06B | 24.80%9.06B | 76.28%7.26B | 76.28%7.26B |
| Cash at the end | -11.20%5.25B | -9.77%6.76B | -43.59%5.92B | -17.90%7.5B | 31.12%10.49B | 32.99%9.13B | -11.69%8B | -4.97%6.87B | 24.80%9.06B | 21.45%7.22B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"